Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Sun Pharma Advanced Research Company
- 20 Oct 2016 Status changed from recruiting to completed.
- 08 Mar 2016 Planned End Date changed from 1 Apr 2016 to 1 Jul 2016, according to ClinicalTrials.gov record.
- 08 Mar 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.